SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001297184-19-000038
Filing Date
2019-08-09
Accepted
2019-08-08 19:11:20
Documents
93
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q amph-20190630x10q.htm 10-Q 2902034
2 EX-10.1 amph-20190630ex1010169c9.htm EX-10.1 509606
3 EX-10.2 amph-20190630ex102e66122.htm EX-10.2 73058
4 EX-31.1 amph-20190630ex311d4e731.htm EX-31.1 22857
5 EX-31.2 amph-20190630ex3129b5ce2.htm EX-31.2 22977
6 EX-32.1 amph-20190630ex3219d0e34.htm EX-32.1 12338
7 EX-32.2 amph-20190630ex32239d73e.htm EX-32.2 12307
  Complete submission text file 0001297184-19-000038.txt   12131411

Data Files

Seq Description Document Type Size
8 EX-101.INS amph-20190630.xml EX-101.INS 3010106
9 EX-101.SCH amph-20190630.xsd EX-101.SCH 68812
10 EX-101.CAL amph-20190630_cal.xml EX-101.CAL 76020
11 EX-101.DEF amph-20190630_def.xml EX-101.DEF 210421
12 EX-101.LAB amph-20190630_lab.xml EX-101.LAB 497250
13 EX-101.PRE amph-20190630_pre.xml EX-101.PRE 442883
Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Filer) CIK: 0001297184 (see all company filings)

IRS No.: 330702205 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36509 | Film No.: 191010983
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences